Abby Resnick-Parigian is Counsel in the Mass Tort/Class Actions group at Wilentz, Goldman & Spitzer, P.A. Ms. Resnick-Parigian focuses her practice on asbestos litigation, products liability, and defective drug litigation. Over the past 25 years, Ms. Resnick-Parigian and her team have collected settlements in excess of one billion dollars for their clients, who were injured by asbestos, defective drugs, defective medical devices, chemicals, and environmental pollution.
With regard to her asbestos litigation practice, Ms. Resnick-Parigian represents trade workers, including insulators, plumbers, pipefitters, auto mechanics, and carpenters afflicted by occupational and environmental illnesses, such as asbestosis, certain cancers and mesothelioma.
In addition to asbestos litigation, Ms. Resnick-Parigian also represents individuals who have been injured by defective hip implants manufactured by different manufacturers, including, DePuy, Stryker, and Zimmer. Some of the implants are “metal on metal.” These metal-on-metal hip implants are made up of a metal ball which replaces the ball at the top of the thigh bone (femur) as well as a metal cup which acts as the socket. The repeated contact of these two metal surfaces can result in premature failing of the implants as well as pitting, loosening, corrosion, infection and elevation of chromium and cobalt levels in the bloodstream, requiring painful revision surgeries. Other non-metal hip implants have failed prematurely, also requiring painful revision surgeries. Ms. Resnick-Parigian also represents individuals injured by defective knee implants. These individuals have suffered premature failures and loosening of their implants due to defects, requiring painful revision surgeries.
Ms. Resnick-Parigian has also represented individuals who were harmed by defective drugs, including individuals who developed cancer as a result of taking those prescription drugs. It was claimed that the drug manufacturers failed to adequately warn of the dangers associated with the ingestion of these drugs.
On a pro bono basis, Ms. Resnick-Parigian represented two clients in the September 11th Victim Compensation Fund Program, one of whom had lost her husband when the North Tower collapsed and one individual who worked in the area of the World Trade Center and suffered serious lung disease from his inhalation of dust and debris when the Twin Towers collapsed. Both were awarded damages.
In the course of her practice in New York City, Ms. Resnick-Parigian participated in the Brooklyn Navy Yard asbestos trials in both New York Supreme Court and in the United States District Court, where she obtained combined verdicts in excess of six million dollars. In addition to her asbestos work, Ms. Resnick-Parigian successfully tried and settled cases in the areas of lead poisoning, premises liability, motor vehicle accidents, slip and falls, and numerous other plaintiff personal injury cases.
In 1996, Ms. Resnick-Parigian successfully tried and then retried a case in the United States District Court for the Southern District of New York, involving a defective meat grinder, which caused her client’s hand to be amputated. The retrial resulted in a jury verdict in excess of one million dollars. The matter was appealed by the defendants. The meat grinder had been modified and its safety guard removed, but Ms. Resnick-Parigian argued that the manufacturer was still under a duty to warn of dangers associated with potential modifications after the sale of the product. The Court of Appeals, Second Circuit, agreed and new law in the state of New York was established regarding a manufacturer’s duty to warn of potential modifications. (In re Liriano v. Hobart Corp., 170 F3d 264 (2d Cir., 1999)).
Prior to her work with Wilentz, she practiced in New York City for eleven years as a trial attorney, and in Philadelphia for three years.
Ms. Resnick-Parigian has lectured in the area of breast implant litigation, products liability litigation and asbestos litigation. She also appeared on Court TV, as a participant in a mock mediation.